세계의 생명공학 서비스 시장 보고서(2025년)

Biotechnology services involve the modification of living microorganisms to produce customized biotechnology products for medical, pharmaceutical, and scientific laboratories on a contract or custom basis. These services contribute to the development of breakthrough products and technologies aimed at addressing diseases, environmental concerns, hunger, energy efficiency, and cleaner industrial processes.

Key types of biotechnology services include prevention and disease control, public engagement activities, health education and research, food biotechnology services, donor recruitment, tissue collection, cell processing and isolation, and research and development. Food biotechnology services cover various technologies applied in crops, livestock, forestry, fisheries, aquaculture, and agro-industry. These services are utilized for genetic improvement, conservation of genetic resources, disease diagnosis, vaccine development, and fermented food production. Applications of biotechnology services span the pharmaceutical, biotechnological, academic, clinical trial, and healthcare sectors, with usage by Clinical Research Organizations (CROs), Contract Manufacturers Organizations (CMOs), and Contract Research and Manufacturing Services (CRAMS).

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the ensuing trade tensions in spring 2025 are taking a toll on the professional services sector, especially within legal, consulting, architectural, and engineering fields. Increased duties on imported technology, software, office hardware, and digital infrastructure have pushed up operational costs for firms that rely on global systems and resources. Cross-border consulting engagements are experiencing delays and higher expenses due to elevated travel costs and limited access to international data and tools. Moreover, industries heavily impacted by tariffs such as manufacturing, construction, and logistics are reducing their reliance on outsourced services, dampening demand for professional support. In response, service providers are reassessing pricing models, strengthening ties with domestic vendors, and accelerating the adoption of AI and automation to maintain profitability and client satisfaction in an increasingly volatile environment.

The biotechnology services market research report is one of a series of new reports from The Business Research Company that provides biotechnology services market statistics, including biotechnology services industry global market size, regional shares, competitors with a biotechnology services market share, detailed biotechnology services market segments, market trends and opportunities, and any further data you may need to thrive in the biotechnology services industry. This biotechnology services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The biotechnology services market size has grown rapidly in recent years. It will grow from $162.19 billion in 2024 to $178.54 billion in 2025 at a compound annual growth rate (CAGR) of 10.1%. The growth in the historic period can be attributed to strong economic growth in emerging markets, increased collaborations with other research institutes and companies, and increased demand for food.

The biotechnology services market size is expected to see rapid growth in the next few years. It will grow to $279.09 billion in 2029 at a compound annual growth rate (CAGR) of 11.8%. The growth in the forecast period can be attributed to the rapid advancements in technology, rising non-communicable diseases, emphasis on innovation, rising demand for agriculture-based biotechnology services, growing demand for synthetic biology, developments and improvements in drug research, growth in personalized treatment, and collaboration and partnership. Major trends in the forecast period include strategic collaborations, integrating data management systems through cloud technology, development of next-generation sequencing technology, adapting digitalizing techniques in conducting clinical trials, implementing automated solutions, deploying artificial intelligence technologies, and investment in synthetic biology to develop products and solutions.

The forecast of 11.8% growth over the next five years reflects a modest reduction of 0.1% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to challenge U.S. labs by increasing costs for clustered regularly interspaced short palindromic repeats gene-editing kits and next-gen sequencing reagents sourced from South Korea and Finland, hampering research progress and inflating biotech startup operational budgets. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing prevalence of conditions such as hepatitis B, diabetes, and cancer is fueling biotechnology research. Biotechnology utilizes research tools from biology and chemistry to examine the genetic material of bacteria and viruses to identify disease-causing agents. Among biopharma companies, oncology research stands out as the most significant focus. Advances in medical applications include stem cell treatments utilizing monoclonal antibodies and genome sequencing. For example, in June 2024, the National Health Service (NHS), a UK-based government department, reported that in 2023, it identified over half a million (549,000) additional individuals in England at risk of developing type 2 diabetes, raising the total number of people with non-diabetic hyperglycemia, or pre-diabetes, registered with a general practitioner (GP) to 3,615,330. This marks a notable increase from 3,065,825 in 2022, reflecting a rise of nearly 20%. Additionally, in February 2024, the World Health Organization (WHO), a Switzerland-based intergovernmental organization, projected that by 2050, there would be over 35 million new cancer cases, representing a 77% increase compared to an estimated 20 million cases in 2022. Consequently, the rising prevalence of diseases and significant investments in R&D are expected to drive growth in the biotechnology services market.

The escalating demand for clinical solutions catering to chronic disease treatments is set to be a significant driver for the expansion of the biotechnology services market. Chronic diseases encompass enduring medical conditions persisting for an extended duration, typically three months or more. Biotechnology services play a pivotal role in offering innovative clinical solutions for managing chronic diseases, including advanced therapies, precision medicine, and targeted treatments personalized to individual patients. These advancements significantly enhance the management and outcomes of chronic ailments. For instance, as per the World Health Organization (WHO) in September 2022, chronic diseases account for 74% of global deaths, amounting to 41 million fatalities annually. This includes 17.9 million deaths attributed to cardiovascular diseases, 9.3 million to cancer, 4.1 million to chronic respiratory diseases, and 2.0 million to diabetes. Hence, the mounting demand for clinical solutions tailored to chronic disease treatment is a driving force behind the growth of the biotechnology services market.

Collaborations and partnerships among industry players are increasingly becoming a trend in the biotech services sector. For example, in April 2024, ICL Partners, an Israel-based manufacturing company, joined forces with Ideelab Biotechnology, a Brazil-based biotechnology firm, to expedite the development of innovative biological technologies for agriculture, with an emphasis on sustainable and regenerative solutions. By harnessing Ideelab's expertise in advanced biologicals alongside ICL's leadership in plant nutrition and physiology, the partnership aims to develop next-generation products that tackle global agricultural challenges and improve food production.

Key companies within the biotechnology services market are dedicated to pioneering innovative therapies, such as biomarker algorithms for the primary treatment of patients with non-small cell lung cancer (NSCLC). Biomarker algorithms encompass mathematical or computational models integrating data from multiple biological indicators to provide comprehensive assessments of specific medical conditions. For instance, in April 2023, Strata Oncology Inc., a US-based precision oncology company, introduced Strata Select-a groundbreaking molecular profiling test for advanced cancer patients. Noteworthy for being the first immunotherapy biomarker algorithm covered by Medicare across solid tumors, Strata Select empowers oncologists to make more informed treatment decisions, thereby enhancing patient outcomes.

In December 2023, Eli Lilly and Company, a US-based pharmaceutical firm, acquired POINT Biopharma Global Inc. for an undisclosed sum. This strategic acquisition aims to enhance Lilly's oncology expertise, particularly in advanced radioligand therapies designed to treat various forms of cancer. POINT Biopharma Global Inc. is a US-based biotechnology company recognized for its innovative methods in cancer treatment.

Major companies operating in the biotechnology services market include Parexel International Corporation, Thermo Fisher Scientific, Laboratory Corporation of America Holdings, IQVIA, ICON plc, Charles River Laboratories, Syneos Health, Sartorius AG, Precision for Medicine Inc., Novartis, Eppendorf Asia Pacific Sdn. Bhd., Emmessar Biotech & Nutrition Ltd, Vcanbio Cell & Gene Engineering Corp., Ltd, Ke Rui Gene, Absea Biotechnology Ltd, CStone Pharm-B, Daiichi Sankyo, bitBiome, Taisho Pharmaceutical, AGC Biologics, Hamamatsu Pharma Research, Artios Pharma, AstraZeneca, Bio Products Laboratory (BPL), Cambridge Bioscience, Shire Pharmaceuticals Ltd, BTG Ltd, eXmoor Pharma, 4D Pharma PLC, Touchlight Genetics, Ophidia Medical Technologies, ATAI Life Sciences, Phaseform, Evotec, Sanity Group, Primmbiotech Vaccitech, Biolat, Asla-Biotech, Genera, Anima Lab, Silvanols, OU TBD-Biodiscovery, Qvalitas Arstikeskus AS, Concise Systems OU, GPE Globalpharma OU, Belarusian National Biotechnology Corporation, Innothera, Olainfarm, Pharmaidea, Amgen Inc., Gilead Sciences, Celgene Corporation, Biogen Inc., Vertex Pharmaceuticals, Illumina, Inc., Regeneron Pharmaceuticals Inc., Alexion Pharmaceuticals, Hemostemix Inc., Resverlogix Corporation, Zenith Epigenetics Corp., Bayer, AMEGA Biotech, Pierre Fabre, Pfizer, Quantificare, Apsen Farmaceutica, BioMarin Pharmaceutical, DK Diagnostics, Biosonda Biotechnology, Laboratorios Legrand, Biomerics, Julphar Pharmaceuticals, Medpharma, Pharmax, Neopharma, City Breeze Technical Services, CinnaGen, BioSun Pharmed, AryoGen Pharmed, 4Clinics, 54gene, Amoun, Aspen Pharmacare, BBI Solutions, BioTech Africa, ClinArt MENA, Crux Pharmaceuticals, Genesis Pharmaceuticals, Massive Genomics, Mayne Pharma, Sanofi Genzyme, Teleflex Medical, The Micron Group

Asia-Pacific was the largest region in the biotechnology services market in 2024. North America was the second largest region in the global biotechnology services market analysis. The regions covered in the biotechnology services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the biotechnology services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The biotechnology services market consists of revenue earned by entities that engage in conducting research and experimental development in biotechnology. Numerous global issues are helped by biotechnology, including infectious diseases, ageing societies, food security, energy security, and climate change, to name a few. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biotechnology Services Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on biotechnology services market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for biotechnology services ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The biotechnology services market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Service: Prevention And Disease Control, Public Engagement Activities, Health Education And Research, Food Biotechnology Services, Donor Recruitment, Tissue Collection, Cell Processing And Isolation, Research And Development
• 2) By Industry: Clinical Research Organizations (CROS), Contract Manufacturers Organizations (CMOS), And Contract Research And Manufacturing Services (CRAMS)
• 3) By Area Of Application: Pharmaceutical, Biotechnology, Academic, Clinical Trial, Healthcare Sectors, Others
• Subsegments:
• 1) By Prevention And Disease Control: Vaccination Services; Disease Surveillance
• 2) By Public Engagement Activities: Awareness Campaigns; Community Outreach Programs
• 3) By Health Education And Research: Medical Training Programs; Research Grants And Fellowships
• 4) By Food Biotechnology Services: Genetically Modified Crop Services; Food Safety Testing
• 5) By Donor Recruitment: Blood Donor Recruitment; Organ Donor Recruitment
• 6) By Tissue Collection: Blood Tissue Collection; Biopsy Tissue Collection
• 7) By Cell Processing And Isolation: Stem Cell Processing; Immune Cell Isolation
• 8) By Research And Development: Drug Discovery Services; Clinical Research
• Companies Mentioned: Parexel International Corporation; Thermo Fisher Scientific; Laboratory Corporation of America Holdings; IQVIA; ICON plc; Charles River Laboratories; Syneos Health; Sartorius AG; Precision for Medicine Inc.; Novartis; Eppendorf Asia Pacific Sdn. Bhd.; Emmessar Biotech & Nutrition Ltd; Vcanbio Cell & Gene Engineering Corp., Ltd; Ke Rui Gene; Absea Biotechnology Ltd; CStone Pharm-B; Daiichi Sankyo; bitBiome; Taisho Pharmaceutical; AGC Biologics; Hamamatsu Pharma Research; Artios Pharma; AstraZeneca; Bio Products Laboratory (BPL); Cambridge Bioscience; Shire Pharmaceuticals Ltd; BTG Ltd; eXmoor Pharma; 4D Pharma PLC; Touchlight Genetics; Ophidia Medical Technologies; ATAI Life Sciences; Phaseform; Evotec; Sanity Group; Primmbiotech Vaccitech; Biolat; Asla-Biotech; Genera; Anima Lab; Silvanols; OU TBD-Biodiscovery; Qvalitas Arstikeskus AS; Concise Systems OU; GPE Globalpharma OU; Belarusian National Biotechnology Corporation; Innothera; Olainfarm; Pharmaidea; Amgen Inc.; Gilead Sciences; Celgene Corporation; Biogen Inc.; Vertex Pharmaceuticals; Illumina, Inc.; Regeneron Pharmaceuticals Inc.; Alexion Pharmaceuticals; Hemostemix Inc.; Resverlogix Corporation; Zenith Epigenetics Corp.; Bayer; AMEGA Biotech; Pierre Fabre; Pfizer; Quantificare; Apsen Farmaceutica; BioMarin Pharmaceutical; DK Diagnostics; Biosonda Biotechnology; Laboratorios Legrand; Biomerics; Julphar Pharmaceuticals; Medpharma; Pharmax; Neopharma; City Breeze Technical Services; CinnaGen; BioSun Pharmed; AryoGen Pharmed; 4Clinics; 54gene; Amoun; Aspen Pharmacare; BBI Solutions; BioTech Africa; ClinArt MENA; Crux Pharmaceuticals; Genesis Pharmaceuticals; Massive Genomics; Mayne Pharma; Sanofi Genzyme; Teleflex Medical; The Micron Group
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Biotechnology Services Market Characteristics

3. Biotechnology Services Market Trends And Strategies

4. Biotechnology Services Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Biotechnology Services Growth Analysis And Strategic Analysis Framework

• 5.1. Global Biotechnology Services PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Biotechnology Services Market Growth Rate Analysis
• 5.4. Global Biotechnology Services Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Biotechnology Services Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Biotechnology Services Total Addressable Market (TAM)

6. Biotechnology Services Market Segmentation

• 6.1. Global Biotechnology Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Prevention And Disease Control
• Public Engagement Activities
• Health Education And Research
• Food Biotechnology Services
• Donor Recruitment
• Tissue Collection
• Cell Processing And Isolation
• Research And Development
• 6.2. Global Biotechnology Services Market, Segmentation By Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Clinical Research Organizations (CROs)
• Contract Manufacturers Organizations (CMOs)
• Contract Research And Manufacturing Services (CRAMS)
• 6.3. Global Biotechnology Services Market, Segmentation By Area Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceutical
• Biotechnology
• Academic
• Clinical Trial
• Healthcare Sectors
• Others
• 6.4. Global Biotechnology Services Market, Sub-Segmentation Of Prevention And Disease Control, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Vaccination Services
• Disease Surveillance
• 6.5. Global Biotechnology Services Market, Sub-Segmentation Of Public Engagement Activities, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Awareness Campaigns
• Community Outreach Programs
• 6.6. Global Biotechnology Services Market, Sub-Segmentation Of Health Education And Research, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medical Training Programs
• Research Grants And Fellowships
• 6.7. Global Biotechnology Services Market, Sub-Segmentation Of Food Biotechnology Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Genetically Modified Crop Services
• Food Safety Testing
• 6.8. Global Biotechnology Services Market, Sub-Segmentation Of Donor Recruitment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Blood Donor Recruitment
• Organ Donor Recruitment
• 6.9. Global Biotechnology Services Market, Sub-Segmentation Of Tissue Collection, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Blood Tissue Collection
• Biopsy Tissue Collection
• 6.10. Global Biotechnology Services Market, Sub-Segmentation Of Cell Processing And Isolation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Stem Cell Processing
• Immune Cell Isolation
• 6.11. Global Biotechnology Services Market, Sub-Segmentation Of Research And Development, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drug Discovery Services
• Clinical Research

7. Biotechnology Services Market Regional And Country Analysis

• 7.1. Global Biotechnology Services Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Biotechnology Services Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Biotechnology Services Market

• 8.1. Asia-Pacific Biotechnology Services Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Biotechnology Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Biotechnology Services Market, Segmentation By Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Biotechnology Services Market, Segmentation By Area Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Biotechnology Services Market

• 9.1. China Biotechnology Services Market Overview
• 9.2. China Biotechnology Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Biotechnology Services Market, Segmentation By Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Biotechnology Services Market, Segmentation By Area Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Biotechnology Services Market

• 10.1. India Biotechnology Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Biotechnology Services Market, Segmentation By Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Biotechnology Services Market, Segmentation By Area Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Biotechnology Services Market

• 11.1. Japan Biotechnology Services Market Overview
• 11.2. Japan Biotechnology Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Biotechnology Services Market, Segmentation By Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Biotechnology Services Market, Segmentation By Area Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Biotechnology Services Market

• 12.1. Australia Biotechnology Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Biotechnology Services Market, Segmentation By Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Biotechnology Services Market, Segmentation By Area Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Biotechnology Services Market

• 13.1. Indonesia Biotechnology Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Biotechnology Services Market, Segmentation By Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Biotechnology Services Market, Segmentation By Area Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Biotechnology Services Market

• 14.1. South Korea Biotechnology Services Market Overview
• 14.2. South Korea Biotechnology Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Biotechnology Services Market, Segmentation By Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Biotechnology Services Market, Segmentation By Area Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Biotechnology Services Market

• 15.1. Western Europe Biotechnology Services Market Overview
• 15.2. Western Europe Biotechnology Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Biotechnology Services Market, Segmentation By Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Biotechnology Services Market, Segmentation By Area Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Biotechnology Services Market

• 16.1. UK Biotechnology Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Biotechnology Services Market, Segmentation By Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Biotechnology Services Market, Segmentation By Area Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Biotechnology Services Market

• 17.1. Germany Biotechnology Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Biotechnology Services Market, Segmentation By Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Biotechnology Services Market, Segmentation By Area Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Biotechnology Services Market

• 18.1. France Biotechnology Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Biotechnology Services Market, Segmentation By Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Biotechnology Services Market, Segmentation By Area Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Biotechnology Services Market

• 19.1. Italy Biotechnology Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Biotechnology Services Market, Segmentation By Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Biotechnology Services Market, Segmentation By Area Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Biotechnology Services Market

• 20.1. Spain Biotechnology Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Biotechnology Services Market, Segmentation By Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Biotechnology Services Market, Segmentation By Area Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Biotechnology Services Market

• 21.1. Eastern Europe Biotechnology Services Market Overview
• 21.2. Eastern Europe Biotechnology Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Biotechnology Services Market, Segmentation By Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Biotechnology Services Market, Segmentation By Area Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Biotechnology Services Market

• 22.1. Russia Biotechnology Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Biotechnology Services Market, Segmentation By Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Biotechnology Services Market, Segmentation By Area Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Biotechnology Services Market

• 23.1. North America Biotechnology Services Market Overview
• 23.2. North America Biotechnology Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Biotechnology Services Market, Segmentation By Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Biotechnology Services Market, Segmentation By Area Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Biotechnology Services Market

• 24.1. USA Biotechnology Services Market Overview
• 24.2. USA Biotechnology Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Biotechnology Services Market, Segmentation By Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Biotechnology Services Market, Segmentation By Area Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Biotechnology Services Market

• 25.1. Canada Biotechnology Services Market Overview
• 25.2. Canada Biotechnology Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Biotechnology Services Market, Segmentation By Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Biotechnology Services Market, Segmentation By Area Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Biotechnology Services Market

• 26.1. South America Biotechnology Services Market Overview
• 26.2. South America Biotechnology Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Biotechnology Services Market, Segmentation By Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Biotechnology Services Market, Segmentation By Area Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Biotechnology Services Market

• 27.1. Brazil Biotechnology Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Biotechnology Services Market, Segmentation By Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Biotechnology Services Market, Segmentation By Area Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Biotechnology Services Market

• 28.1. Middle East Biotechnology Services Market Overview
• 28.2. Middle East Biotechnology Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Biotechnology Services Market, Segmentation By Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Biotechnology Services Market, Segmentation By Area Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Biotechnology Services Market

• 29.1. Africa Biotechnology Services Market Overview
• 29.2. Africa Biotechnology Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Biotechnology Services Market, Segmentation By Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Biotechnology Services Market, Segmentation By Area Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Biotechnology Services Market Competitive Landscape And Company Profiles

• 30.1. Biotechnology Services Market Competitive Landscape
• 30.2. Biotechnology Services Market Company Profiles
  • 30.2.1. Parexel International Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. IQVIA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. ICON plc Overview, Products and Services, Strategy and Financial Analysis

31. Biotechnology Services Market Other Major And Innovative Companies

• 31.1. Charles River Laboratories
• 31.2. Syneos Health
• 31.3. Sartorius AG
• 31.4. Precision for Medicine Inc.
• 31.5. Novartis
• 31.6. Eppendorf Asia Pacific Sdn. Bhd.
• 31.7. Emmessar Biotech & Nutrition Ltd
• 31.8. Vcanbio Cell & Gene Engineering Corp., Ltd
• 31.9. Ke Rui Gene
• 31.10. Absea Biotechnology Ltd
• 31.11. CStone Pharm-B
• 31.12. Daiichi Sankyo
• 31.13. bitBiome
• 31.14. Taisho Pharmaceutical
• 31.15. AGC Biologics

32. Global Biotechnology Services Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Biotechnology Services Market

34. Recent Developments In The Biotechnology Services Market

35. Biotechnology Services Market High Potential Countries, Segments and Strategies

• 35.1 Biotechnology Services Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Biotechnology Services Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Biotechnology Services Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer